Focus: Countable Labs is a diagnostics company specializing in identifying rare events in PCR workflows, focused on rare disease applications. The company is early-stage and pre-revenue based on available data.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Early-stage rare disease diagnostics play with intriguing technology but material execution risk; suitable only for founders-mentality candidates comfortable with uncertainty.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Countable Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Countable Labs's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo